|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: SUCCESSORIES INC, 10-Q, EX-10.24, 2000-12-08 |
Next: CENTAUR PHARMACEUTICALS INC, 8-K, 2000-12-08 |
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> FEB-03-2001
<PERIOD-START> JAN-30-2000
<PERIOD-END> OCT-28-2000
<CASH> 967,000
<SECURITIES> 0
<RECEIVABLES> 5,173,000
<ALLOWANCES> 483,000
<INVENTORY> 8,232,000
<CURRENT-ASSETS> 15,859,000
<PP&E> 19,654,000
<DEPRECIATION> 13,081,000
<TOTAL-ASSETS> 29,803,000
<CURRENT-LIABILITIES> 6,204,000
<BONDS> 0
0
6,000
<COMMON> 89,000
<OTHER-SE> 21,126,000
<TOTAL-LIABILITY-AND-EQUITY> 29,803,000
<SALES> 36,580,000
<TOTAL-REVENUES> 37,719,000
<CGS> 16,653,000
<TOTAL-COSTS> 20,218,000
<OTHER-EXPENSES> 149,000
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 1,000,000
<INCOME-PRETAX> (301,000)
<INCOME-TAX> 0
<INCOME-CONTINUING> (301,000)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (301,000)
<EPS-BASIC> (0.06)
<EPS-DILUTED> (0.06)
</TABLE>
|
|